Agios Pharmaceuticals, Inc. (AGIO)
NASDAQ: AGIO · Real-Time Price · USD
36.21
+0.05 (0.14%)
At close: Aug 5, 2025, 4:00 PM
36.18
-0.03 (-0.08%)
After-hours: Aug 5, 2025, 5:41 PM EDT

Agios Pharmaceuticals Stock Forecast

Stock Price Forecast

The 5 analysts that cover Agios Pharmaceuticals stock have a consensus rating of "Buy" and an average price target of $57.4, which forecasts a 58.52% increase in the stock price over the next year. The lowest target is $51 and the highest is $65.

Price Target: $57.40 (+58.52%)
Analyst Consensus: Buy
TargetLowAverageMedianHigh
Price$51$57.4$57$65
Change+40.85%+58.52%+57.42%+79.51%

Analyst Ratings

The average analyst rating for Agios Pharmaceuticals stock is "Buy". This means that analysts believe this stock is likely to outperform the market over the next twelve months.

Recommendation Trends

RatingMar '25Apr '25May '25Jun '25Jul '25Aug '25
Strong Buy111111
Buy444444
Hold333311
Sell000000
Strong Sell000000
Total888866

Latest Forecasts

AnalystFirmRatingRatingActionPrice TargetUpsideDate
Scotiabank
Scotiabank
Buy
Maintains
$71$65
BuyMaintains$71$65+79.51%Jul 28, 2025
B of A Securities
B of A Securities
Strong Buy
Maintains
$52$51
Strong BuyMaintains$52$51+40.85%Jul 22, 2025
Scotiabank
Scotiabank
Buy
Maintains
$74$71
BuyMaintains$74$71+96.08%May 2, 2025
HC Wainwright & Co.
HC Wainwright & Co.
Strong Buy
Reiterates
$58
Strong BuyReiterates$58+60.18%Feb 24, 2025
Cantor Fitzgerald
Cantor Fitzgerald
Buy
Reiterates
n/a
BuyReiteratesn/an/aDec 18, 2024
More Analyst Ratings

Financial Forecast

Revenue This Year
43.41M
from 36.50M
Increased by 18.94%
Revenue Next Year
130.97M
from 43.41M
Increased by 201.70%
EPS This Year
-7.38
from 11.64
EPS Next Year
-6.78
from -7.38
Fiscal YearFY 2020FY 2021FY 2022FY 2023FY 2024FY 2025FY 2026FY 2027
Period EndingDec 31, 2020Dec 31, 2021Dec 31, 2022Dec 31, 2023Dec 31, 2024Dec 31, 2025Dec 31, 2026Dec 31, 2027
Revenue
--14.24M26.82M36.50M43.41M130.97M339.75M
Revenue Growth
---88.36%36.07%18.94%201.70%159.41%
EPS
-4.7426.55-4.23-6.3311.64-7.38-6.78-4.09
EPS Growth
--------
Forward PE
--------
No. Analysts
-----111110
Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.

Revenue Forecast

Revenue20252026202720282029
High48.5M189.2M473.9M
Avg43.4M131.0M339.8M
Low38.2M91.1M171.5M

Revenue Growth

Revenue Growth20252026202720282029
High
32.8%
335.8%
261.8%
Avg
18.9%
201.7%
159.4%
Low
4.7%
110.0%
30.9%

EPS Forecast

EPS20252026202720282029
High-7.09-5.65-1.76
Avg-7.38-6.78-4.09
Low-7.55-8.27-9.19

EPS Growth

EPS Growth20252026202720282029
High---
Avg---
Low---
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.